Sector. They are actively engaged in the process and the followon when you talk about a prime boost and the major vaccine, the boost being of followon in other Large Pharma Companies but they invested time and resources and opportunity. And that vaccine shows efficacy. And very much the Public Sector, and very clear this was public good. And the polio vaccines, certainly we expect the lions share of Product Development costs by Public Sectors that would be an equitable one. It comes through investment, engage in the product prices. We get into Licensing Agreements that is part of the licensing agreement. A point about the recent successes of got the, they have brought out Rotavirus Vaccine and h p the vaccine, prices under 5 a dose, h p vaccine under 3 per dose for a Rotavirus Vaccine and additional modeling work we would be bringing offline to put on the web site as soon as we finalize a little bit more. We looked at the cost per regimen in that range including implementation of 30 pe
Nick zito, the bill and melanie gates foundation, and all the other investments, important, in european funding declined over the past several years. It made little difference in the overall, and when those big numbers stayed big, stay significant, do we have a robust pipeline the fourth blood gets funded. You heard it from the lead scientists in policy perspective, and the p 5 strategy. And high vaccine resulting in Southern Africa and thailand, up and 31 , we cant not explore that. And on the slide previously, and other ideas will they work . We dont know. That is why we do the Clinical Trial. Clinical Research Needs investment. All of the work around that structure based design, all of these exciting neutralizing antibodies that have their clever code names for what they are, each of those needs to be pursued and they need to be pursued in a different way than we worked before. How do you translate that novel idea into a Clinical Trial . When you walk the halls of a science meeting
Will discuss progress made in the work to combat hiv. One of the speakers is dr. Anthony felty, the head of the allergy and Infectious Diseases department. It should get underway shortly here on cspan. Once again, we are waiting for the start of a program of Health Officials working to combat hiv. We would hear from dr. Anthony fauci, the head of the national of allergies and Infectious Diseases. In the meantime, the city press in africa is reporting that preparatory work is well underway to license an hiv vaccine in south africa. If all goes well, the followup trials are set to begin january, 2017, and could be used for general use by 2019. This was revealed by glenda gray at the hiv research for Prevention Conference that is taking place in cape town. Waiting for the start of this gathering of Health Officials, a discussion on progress made in creating a vaccine to combat hiv. All of the panelist, we understand, are in the room to ,y clipping dr. Anthony fauci head of the National In
Two different things. When you are looking at hearings, you will see more hearings in the senate that look like what you have been seeing in the house over the last several years. Administration officials being called from various departments and agencies to essentially get byed over the coals republican senators who are going to be chairman of these committees for the first time. You are going to see more critical hearings and hearings that are built around topics that are critical of the administration. In terms of legislation, you are probably going to see more markups and more consideration of bills at the Committee Level and when they come out of the last couple in the of years, bills of come out of committee and then sort of disappeared in a number of cases. What mcconnell is at least saying and what he said last coat newsnew conference that if a bill comes out on a bipartisan basis, somebody might actually see it on the floor. You also mentioned an open amendment process. How li
Secretary Sylvia Burwell will speak at the center for American Progress today about the upcoming open Enrollment Period in the Health Insurance marketplace. Shell also discuss her departments efforts to insure the readiness of healthcare. Gov. Our live coverage begins at one p. M. Eastern on cspan. And now a discussion on Current International health and security challenges. Medical and defense analysts discuss the spread of the e ebola virus, Health Concerns related to warfare and the humanitarian crises resulting from conflicts being waged by isis and other terror groups. The event is hosted by the University Center for terrorism study. Its just under two hours. Okay. I guess were ready to start. I want to welcome everybody again to another very, very timely seminar, and i want to thank yona and all of his people really who put this together with a great deal of haste really considering the topic. The Health Challenges that we have, the security responses from ebola to terrorism. And